You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...

In this interview, Dr Tiffany Braley discusses the results of her latest study and best practices for personalized patient ...

The medication, which will be rolled out to patients with relapsing-remitting MS, is thought to be the first in Europe to be ...

Broadening access to cladribine should help more patients avoid hospital and free up clinic time.

A simple algorithm to recommend disease-modifying therapies may help reduce racial and ethnic inequalities in MS treatment, ...

March is MS Awareness Month, and this week we’re spotlighting the nearly one million people in the U.S. living with multiple sclerosis. Julie Hirsch from the National MS Society of Michigan joins us ...

A simple treatment algorithm to aid in the selection of appropriate DMTs reduces racial disparities in patients with ...

Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...

Cog fog can paint columnist Ahna Crum into a corner where nothing flows. As in an early art experiment, she now has a process ...

Scientists from Sweden’s Karolinska Institutet have uncovered new clues about how the Epstein-Barr virus (EBV) might ...

Multiple sclerosis (MS) causes a specific type of ... and cannot prevent the symptoms from returning. Another goal of MS treatment is to prevent further damage to nerve cells.

For the first time, researchers have identified that inflammation—long associated with multiple sclerosis (MS)—appears to ...